Vive la différence: naming structural variants in the human reference genome
© Seal et al.; licensee BioMed Central Ltd. 2013
Received: 26 February 2013
Accepted: 9 April 2013
Published: 1 May 2013
The HUGO Gene Nomenclature Committee has approved gene symbols for the majority of protein-coding genes on the human reference genome. To adequately represent regions of complex structural variation, the Genome Reference Consortium now includes alternative representations of some of these regions as part of the reference genome. Here, we describe examples of how we name novel genes in these regions and how this nomenclature is displayed on our website, http://genenames.org.
Letter to the Editor
The HUGO Gene Nomenclature Committee (HGNC)  is the only resource with the authority to name human genes. Our philosophy has always been to assign symbols to genes to enable communication and for this nomenclature to evolve as required with new technology and discoveries. Since the initial release of the human genome sequence, we have worked closely with annotators and researchers towards naming all the genes from this source. Historically, we have also approved symbols for genes that are not part of the reference genome where particular communities have requested this. Examples include the naming of structural variants within the human leukocyte antigen (HLA; major histocompatibility complex) and killer-cell immunoglobulin-like receptor (KIR) gene families, both of which have dedicated nomenclature committees [2, 3] that work directly with the HGNC, providing us with further confidence in the existence of these genes.
Since 2009, the human reference genome assembly has been maintained by the Genome Reference Consortium (GRC), a body of experts in genome assembly and annotation . As part of the human reference genome, the GRC includes representations of common structural variation in the form of separate assembly units, which they call novel patches upon release and then label alternate loci when they are subsequently incorporated into the next version of the human reference genome. The sequence for these regions is submitted by experts in the field and then annotated by members of the GRC. Due to the difficulties in annotating regions of variation consistently and reliably, we have chosen to restrict our future naming of structural variants to those annotated by the GRC.
The alternate loci in the current GRC human reference genome version, GRCh37, encompass most of the structural variants that we had previously named. This includes alternate loci for seven major histocompatibility complex (MHC) haplotypes (see Figure 1 in ), which were previously sequenced and annotated by the MHC Haplotype Consortium . Their inclusion into the reference means that each haplotype has its own assembly unit with a unique sequence accession that contains anchor sequences to allow the correct placement of the alternate locus onto 6p21.3. The haplotypes contain several named HLA genes (HLA-DRB3, HLA-DRB4, HLA-DRB2, HLA-DRB7 and HLA-DRB8) that were not included in previous genome versions. It should be noted that these haplotypes also carry other named genes that were present in previous human genome assemblies, such as HLA-C. The same gene symbol will always be used to refer to a gene whether it is on the reference-assembled chromosomes or on a variant haplotype.
Structural variants do not have to correspond to the entire haplotypes to be included in the genome reference and may represent smaller structurally complex regions. Previously, the GRC contacted us to request a symbol for a small genomic deletion on chromosome 22 that is currently annotated on a novel patch. This common functional variant is the result of a deletion between the fifth exon of APOBEC3A and the eighth exon of APOBEC3B. As the deletion affects both the APOBEC3A and APOBEC3B genes, it cannot be considered as an allele of either gene, and since it is found in over 20% of the worldwide population, we decided that it would be useful for the research community if we assigned it a specific gene symbol. We have named this variant APOBEC3A_B for “APOBEC3A and APOBEC3B deletion hybrid”, and we include the chromosomal location “22q13 GRCh37 novel patch” and the sequence accession [GenBank:GL383583] for the patch in the Gene Symbol Report. The novel patch will be incorporated into the human reference assembly as part of the next release, GRCh38, and we will update the chromosomal location to include the new assembly unit name when this occurs. The GRC has also included eight novel patches for the leukocyte receptor complex, meaning that most of the KIR genes that we had previously named now have representation in the reference genome. Only KIR2DL5B and KIR2DS3 are still not represented; therefore, we have displayed their chromosomal location as “19q13.4 unplaced”.
We have also created a separate table called Alternative Loci Statistics on our Statistics and Downloads page  so that our users may easily view and download data on all named genes that are only found on alternate loci (Figure 1B). We will continue to work with the GRC to provide nomenclature for novel genes annotated on alternate loci and novel patches. If you have any queries, please contact us at firstname.lastname@example.org, and to follow updates on our project, please subscribe to our newsletter using our feedback form .
This work was supported by the Wellcome Trust (099129/Z/12/Z) and the National Human Genome Research Institute (P41 HG03345).
- Gray KA, Daugherty LC, Gordon SM, Seal RL, Wright MW, Bruford EA: Genenames.org: the HGNC resources in 2013. Nucleic Acids Res. 2013, 41 (D1): D545-D552. 10.1093/nar/gks1066.PubMed CentralView ArticlePubMedGoogle Scholar
- Marsh SG: Nomenclature for factors of the HLA system, update July 2012. Hum Immunol. 2013, 74 (2): 263-266. 10.1016/j.humimm.2012.10.015.View ArticleGoogle Scholar
- Marsh SG, Parham P, Dupont B, Geraghty DE, Trowsdale J, Middleton D, Vilches C, Carrington M, Witt C, Guethlein LA, Shilling H, Garcia CA, Hsu KC, Wain H: Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. Tissue Antigens. 2003, 62 (1): 79-86. 10.1034/j.1399-0039.2003.00072.x.View ArticlePubMedGoogle Scholar
- Church DM, Schneider VA, Graves T, Auger K, Cunningham F, Bouk N, Chen HC, Agarwala R, McLaren WM, Ritchie GR, Albracht D, Kremitzki M, Rock S, Kotkiewicz H, Kremitzki C, Wollam A, Trani L, Fulton L, Fulton R, Matthews L, Whitehead S, Chow W, Torrance J, Dunn M, Harden G, Threadgold G, Wood J, Collins J, Heath P, Griffiths G: Modernizing reference genome assemblies. PLoS Biol. 2011, 9 (7): e1001091-10.1371/journal.pbio.1001091.PubMed CentralView ArticlePubMedGoogle Scholar
- Horton R, Gibson R, Coggill P, Miretti M, Allcock RJ, Almeida J, Forbes S, Gilbert JG, Halls K, Harrow JL, Hart E, Howe K, Jackson DK, Palmer S, Roberts AN, Sims S, Stewart A, Traherne JA, Trevanion S, Wilming L, Rogers J, de Jong PJ, Elliott JF, Sawcer Stephen , Todd JA, Trowsdale J, Beck S: Variation analysis and gene annotation of eight MHC haplotypes: the MHC Haplotype Project. Immunogenetics. 2008, 60 (1): 1-18. 10.1007/s00251-007-0262-2.PubMed CentralView ArticlePubMedGoogle Scholar
- Kidd JM, Newman TL, Tuzun E, Kaul R, Eichler EE: Population stratification of a common APOBEC gene deletion polymorphism. PLoS Genet. 2007, 3 (4): e63-10.1371/journal.pgen.0030063.PubMed CentralView ArticlePubMedGoogle Scholar
- HGNC Statistics and Downloads. http://www.genenames.org/cgi-bin/hgnc_stats,
- HGNC Feedback Form. http://www.genenames.org/cgi-bin/hgnc_feedback.pl,
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.